Quantitative Nanostructure−Activity Relationship Modeling
Source abstract
Abstract
Evaluation of biological effects, both desired and undesired, caused by manufactured nanoparticles (MNPs) is of critical importance for nanotechnology. Experimental studies, especially toxicological, are time-consuming, costly, and often impractical, calling for the development of efficient computational approaches capable of predicting biological effects of MNPs. To this end, we have investigated the potential of cheminformatics methods such as quantitative structure-activity relationship (QSAR) modeling to establish statistically significant relationships between measured biological activity profiles of MNPs and their physical, chemical, and geometrical properties, either measured experimentally or computed from the structure of MNPs. To reflect the context of the study, we termed our approach quantitative nanostructure-activity relationship (QNAR) modeling. We have employed two representative sets of MNPs studied recently using in vitro cell-based assays: (i) 51 various MNPs with diverse metal cores (Proc. Natl. Acad. Sci. 2008, 105, 7387-7392) and (ii) 109 MNPs with similar core but diverse surface modifiers (Nat. Biotechnol. 2005, 23, 1418-1423). We have generated QNAR models using machine learning approaches such as support vector machine (SVM)-based classification and k nearest neighbors (kNN)-based regression; their external prediction power was shown to be as high as 73% for classification modeling and having an R(2) of 0.72 for regression modeling. Our results suggest that QNAR models can be employed for: (i) predicting biological activity profiles of novel nanomaterials, and (ii) prioritizing the design and manufacturing of nanomaterials toward better and safer products.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Carbon Nanotubes in Composites · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Molecular Modeling, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599
Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114
Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599
References (44)
Show source-provided references
1. Schmidt, K.Green Nanotechnology: It’s Easier Than You Think; Project on Emerging Nanotechnologies, April 26, 2007, Washington, DC, 2007; pp, 1–−36.
2. Service R. F. · Science · 2004 · 304 · 173210.1126/science.304.5678.1732 ↗
3. Heinemann M. · Hum. Exp. Toxicol. · 2009 · 28 · 40710.1177/0960327109105149 ↗
4. Kipen H. M. · Am. J. Physiol. Lung Cell. Mol. Physiol. · 2005 · 289 · 69610.1152/ajplung.00277.2005 ↗
5. Hart, P.Nanotechnology, Synthetic Biology, & Public Opinion; Project on Emerging Nanotechnologies, September 29, 2009; Washington, DC, 2009;p 1–17
6. Oberdorster G. · Environ. Health Perspect. · 2005 · 113 · 82310.1289/ehp.7339 ↗
7. Bystrzejewska-Piotrowska G. · Waste Manage. · 2009 · 29 · 258710.1016/j.wasman.2009.04.001 ↗
8. Oberdorster G. · J. Intern. Med. · 2010 · 267 · 8910.1111/j.1365-2796.2009.02187.x ↗
9. Nyland J. F. · Hum. Exp. Toxicol. · 2009 · 28 · 39310.1177/0960327109105161 ↗
10. Donaldson K. · Occup. Environ. Med. · 2004 · 61 · 72710.1136/oem.2004.013243 ↗
11. Xia T. · Annu. Rev. Public Health · 2009 · 30 · 13710.1146/annurev.publhealth.031308.100155 ↗
12. Marquis B. J. · Analyst · 2009 · 134 · 42510.1039/b818082b ↗
13. Suh W. H. · Prog. Neurobiol. · 2009 · 87 · 13310.1016/j.pneurobio.2008.09.009 ↗
14. Shvedova A. A. · J. Intern. Med. · 2010 · 267 · 10610.1111/j.1365-2796.2009.02188.x ↗
15. Koziara J. M. · Pharm. Res. · 2005 · 22 · 182110.1007/s11095-005-7547-7 ↗
16. Radomski A. · Br. J. Pharmacol. · 2005 · 146 · 88210.1038/sj.bjp.0706386 ↗
17. Harhaji L. · Eur. J. Pharmacol. · 2007 · 568 · 8910.1016/j.ejphar.2007.04.041 ↗
18. Harhaji L. · Pharm. Res. · 2008 · 25 · 136510.1007/s11095-007-9486-y ↗
19. Kane A. B. · Am. J. Physiol. · 1985 · 249 · 25610.1152/ajpcell.1985.249.3.C256 ↗
20. Kang S. J. · Environ. Mol. Mutagen. · 2008 · 49 · 39910.1002/em.20399 ↗
21. Leonard S. S. · Mol. Cell. Biochem. · 2004 · 255 · 17110.1023/B:MCBI.0000007273.23747.67 ↗
22. Pulskamp K. · Toxicol. Lett. · 2007 · 168 · 5810.1016/j.toxlet.2006.11.001 ↗
23. Meng H. · ACS Nano · 2009 · 3 · 162010.1021/nn9005973 ↗
24. Liu J. · Chem. Res. Toxicol. · 2008 · 21 · 45910.1021/tx700392b ↗
25. Liu J. · Mol. Pharm. · 2009 · 6 · 87310.1021/mp800197v ↗
26. Shaw S. Y. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 738710.1073/pnas.0802878105 ↗
27. Puzyn T. · Small · 2009 · 5 · 249410.1002/smll.200900179 ↗
28. QSAR Expert Group. The Report From the Expert Group on (Quantitative) Structure−Activity Relationships [(Q)SARs] on the Principles for the Validation of (Q)SARs.Series on Testing and Assessment, No. 49; Organisation For Economic Co-operation and Development 2004, 206.
29. Tropsha A. · Curr. Pharm. Des. · 2007 · 13 · 349410.2174/138161207782794257 ↗
30. Weissleder R. · Nat. Biotechnol. · 2005 · 23 · 141810.1038/nbt1159 ↗
31. Varnek A. · Curr. Comput.-Aided Drug Des. · 2008 · 4 · 19110.2174/157340908785747465 ↗
32. Zhu H. · J. Chem. Inf. Model. · 2008 · 48 · 76610.1021/ci700443v ↗
33. Song Y. · Langmuir · 2010 · 26 · 510.1021/la901902t ↗
34. Martin D. · J. Phys. Chem. B · 2007 · 111 · 985310.1021/jp071679x ↗
35. Collins F. S. · Science · 2008 · 319 · 90610.1126/science.1154619 ↗
36. Donaldson K. · Part. Fibre Toxicol. · 2009 · 6 · 1310.1186/1743-8977-6-13 ↗
37. Fourches D. · Chem. Res. Toxicol. · 2010 · 23 · 17110.1021/tx900326k ↗
38. Tetko I. V. · J. Chem. Inf. Model. · 2008 · 48 · 173310.1021/ci800151m ↗
39. Fourches D. · J. Chem. Inf. Model. · 2010 · 50 · 118910.1021/ci100176x ↗
40. Golbraikh A. · J. Mol. Graph. Model. · 2002 · 20 · 26910.1016/S1093-3263(01)00123-1 ↗
41. Todeschini, R.; Consonni, V.Handbook of Molecular Descriptors;Wiley-VCH:Weinheim, Germany, 2000; pp1−667.10.1002/9783527613106 ↗
42. Downs G. · Rev. Comput. Chem. · 2002 · 18 · 1
43. Zheng W. · J. Chem. Inf. Comput. Sci. · 2000 · 40 · 18510.1021/ci980033m ↗
44. Shen M. · J. Med. Chem. · 2003 · 46 · 301310.1021/jm020491t ↗